Taiwan drug seeking Food and Drug Administration permit for human testing

The China Post - An innovative drug for diabetic ulcers, developed by a Taiwanese biomedical research institution, is about to be submitted to the U.S. Food and Drug Administration (FDA) for a permit on human testing, academic sources disclosed yesterday. Full Story